TEK tyrosine kinase, also known as TIE2 or CD202B, is a receptor tyrosine kinase that plays a crucial role in the vascular system. It is predominantly expressed in endothelial cells, which line the interior surface of blood vessels. The TEK receptor is essential for angiogenesis, the process through which new blood vessels form from pre-existing vessels, and for maintaining the integrity of the vascular system .
The TEK receptor tyrosine kinase has a unique extracellular domain that includes two immunoglobulin-like loops, three epidermal growth factor-like repeats, and three fibronectin type III-like repeats . This structure allows it to interact with its primary ligand, angiopoietin-1 (ANGPT1), which activates the receptor by inducing its tyrosine phosphorylation .
Upon activation by ANGPT1, TEK initiates a cascade of downstream signaling pathways that promote endothelial cell survival, migration, and the formation of new blood vessels . This signaling is critical for both physiological processes, such as wound healing and embryonic development, and pathological conditions, including cancer and diabetic retinopathy .
Recombinant TEK tyrosine kinase refers to the protein produced through recombinant DNA technology, which involves inserting the gene encoding TEK into an expression system, such as bacteria or mammalian cells, to produce the protein in large quantities. This recombinant protein is used in various research applications to study its function, interactions, and potential therapeutic uses.